Pamela A. Shaw, Ph.D.6700B Rockledge Drive, MSC 7630Bethesda, MD 20892-7630Phone: 301-451-2450Fax: email@example.comOvernight mail address:6700A Rockledge Drive#5128 Bethesda, MD 20817
Covariate measurement error, statistical evaluation of diagnostic tests, design of medical studies, nutritional and physical activity epidemiology
Curriculum Vitae (PDF)
Shaw PA and Proschan MA. Null but not void: Considerations for hypothesis testing. In press, Statistics in Medicine, 2012.
Shepherd B, Shaw PA and Dodd L. Using audit Information to adjust parameter estimates for data errors in clinical trials. In press, Clinical Trials, 2012.
Proschan MA, Shaw PA. Asymptotics of Bonferroni for dependent normal test statistics. Statistics and Probability Letters, 2011 Jul; 81: 739-748.
Shaw PA, Prentice, R L. Hazard Ratio Estimation for Biomarker-Calibrated Dietary Exposures. Biometrics, Early online access 17 Oct 2011, DOI: 10.1111/j.1541-0420.2011.01690.x.
Prevots DR, Shaw PA, Strickland D, Jackson L A, Raebel M A, Biosky MA, Montes de Oca R, Shea YR, Seltz AE, Holland SM Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory Critical Care Medicine 2010 Oct 1; 182 (7): 970-6.
Fay M P, Shaw P A. Exact and asymptotic weighted logrank tests for interval censored data: the interval R package. Journal of Statistical Software, 2010 Aug; 36 (2): 1-34.
Komati S, Shaw P A, Stubbs N, Mathibedi M J, Malan L, Metcalf J A, Masur H, Hassim S. A Baseline History of Recent Tuberculosis is Associated with Poor Prognosis in a South African HIV Therapy Trial. AIDS, 2010 Jul 31; 24 (12): 1849-55.
Hassim S, Shaw P A, Sangweni P, Malan L, Ntshani E, Mathibedi MJ, Stubbs N, Metcalf J A, Eckes R, Masur H, Komati S. Active Sputum Acquisition Permits Detection of Substantial Rate of Multi-Drug Resistant Tuberculosis (MDR-TB) in a High Risk Population in South Africa. Clinical Infectious Diseases, 2010 Apr 1; 50(7): 1053-9.
Shaw P A Pepe M S, Alonzo T A, Etzioni, R. Methods for Assessing Improvement in Speciﬁcity when a Biomarker is Combined with a Standard Screening Test. (PDF) Statistics of Biopharmacetucial Research, 2009 Feb 1; 1 (1): 18-25.
Prentice R L, Shaw P A, Bingham S A, Beresford S A, Caan B, Neuhouser M L, Patterson R E, Stefanick M L, Satterfield S, Thomson C A, Snetselaar L, Thomas A, Tinker L F. Biomarker-Calibrated Energy and Protein Consumption and Increased Cancer Risk among Postmenopausal Women. American Journal of Epidemiology, 2009 Apr 15;169(8):977-89.
Neuhouser M L, Tinker L, Shaw P A, Schoeller D, Bingham S A, Van Horn L, Beresford S A, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick M L, Assaf A, Runswick S and Prentice RL. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women’s Health Initiative. (PDF) American Journal of Epidemiology, 2008 May 15; 167 (10):1247-59.
Etzioni R, Howlader N, Shaw P A, Ankerst D P, Penson D F, Goodman P J, Thompson I M. Long-term effects of finasteride on PSA Levels: results from the Prostate Cancer Prevention Trial. (PDF) Journal of Urology, 2005 Sep; 174(3):877–81.
Shaw P A, Etzioni R, Zeliadt S, Mariotto A, Karnofski K, Penson D, Weiss N, Feuer E. Ecologic Study of PSA Screening and Prostate Cancer Mortality in Nine Geographic Areas of the US. (PDF) American Journal of Epidemiology, 2004; 160(11):1059–69.
back to top
Last Updated September 30, 2011